Posts filed under: News

MELBOURNE Australia, 09 January 2019 – Telix Pharmaceuticals Limited is pleased to provide an update on its programs. For full details click here....
Continue Reading →
Melbourne (Australia) – 8th January 2019. Telix Pharmaceuticals Limited today announced a strategy update for the TLX591 (prostate therapy) program. The full media release can be accessed here....
Continue Reading →
Melbourne (Australia) – 3rd December 2018. Telix Pharmaceuticals Limited is pleased to provide investors an audio link to the Investor Conference Call hosted by the Company and led by Managing...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. To facilitate shareholder queries,...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. The full media release...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. To facilitate shareholder queries,...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. For market briefing click...
Continue Reading →
Melbourne (Australia), Brussels (Belgium) – 18th of October 2018. Telix Pharmaceuticals Limited has today announced that the Company has received its first European Competent Authority (CA) approval to commence a...
Continue Reading →
Melbourne (Australia) and Nijmegen (the Netherlands) – 17 October 2018. Telix Pharmaceuticals Limited announced that it has concluded a GMP manufacturing agreement with Radboud Translational Medicine B.V. The full media...
Continue Reading →
Melbourne (Australia) and Seibersdorf (Austria) – 16 October 2018. Telix Pharmaceuticals Limited announced that it has entered into a commercial manufacturing agreement with Seibersdorf Labor GmbH. The full media release...
Continue Reading →